NCT07264439

Brief Summary

A device combining a virtual reality (VR) headset with hypnotic scenarios may represent an effective tool to reduce anxiety and opposition during hygiene care in patients with neurocognitive disorders presenting with behavioral and psychological symptoms. The primary objective of this project is to assess the feasibility and effectiveness of VR headsets with hypnotic scenarios compared with standard care in patients with ADRD presenting behavioral disturbances during hygiene care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Sep 2025May 2027

Study Start

First participant enrolled

September 3, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

December 4, 2025

Status Verified

December 1, 2025

Enrollment Period

1.6 years

First QC Date

November 18, 2025

Last Update Submit

December 2, 2025

Conditions

Keywords

Effectivenessvirtual realityhypnotic scenarioshygiene careAlzheimer's disease and related disorders (ADRD)behavioral disturbances

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of VR headsets

    Effectiveness of VR headsets delivering hypnotic scenarios versus standard cares in older adults with ADRD and behavioral disturbances (opposition or agitation), with the aim of reducing apprehension, pain, anxiety, and resistance during hygiene and toileting care. Evaluation with EPADE sclae

    up to 5 weeks

Secondary Outcomes (3)

  • decrease number of patients with behavioral and psychological symptoms in VR headset group

    up to 5 weeks

  • reduced number of psychotropic drug per patient use in VR headset group

    up to 5 weeks

  • Number of patients with improve quality of life in VH headset group

    up to 5 weeks

Study Arms (2)

controlled trial

ACTIVE COMPARATOR
Other: standard cares

VR headset

EXPERIMENTAL

a virtual reality (VR) headset with hypnotic scenarios

Device: VR headset

Interventions

VR headset enabling the management of hypnotic scenarios. The headset will project immersive 3D images and deliver a hypnotic narrative, thus combining VR and hypnosis-based techniques. This intervention will be applied during hygiene and toileting care and compared to standard behavioral management traditionally used in the structures.

VR headset

standard cares

controlled trial

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Residents of the St-Victor center (CHU Amiens-Picardie), including nursing home units, reinforced care units, and long-term care units;
  • Patients diagnosed with ADRD presenting opposition or agitation during hygiene and toileting care;
  • Affiliation to a social security scheme,
  • Informed consent signed by the patient or legal representative.

You may not qualify if:

  • Residents in terminal palliative care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amiens University Hospital

Amiens, 80054, France

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseMental Disorders

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 4, 2025

Study Start

September 3, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

December 4, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations